---
title: Therapeutic targeting of chronic kidney disease-associated DAMPs differentially
  contributing to vascular pathology
date: '2023-10-18'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37849759/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231018180638&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: Chronic Kidney Disease (CKD) is associated with markedly increased cardiovascular
  (CV) morbidity and mortality. Chronic inflammation, a hallmark of both CKD and CV
  diseases (CVD), is believed to drive this association. Pro-inflammatory endogenous
  TLR agonists, Damage-Associated Molecular Patterns (DAMPs), have been found elevated
  in CKD patients' plasma and suggested to promote CVD, however, confirmation of their
  involvement, the underlying mechanism(s), the extent to which individual ...
disable_comments: true
---
Chronic Kidney Disease (CKD) is associated with markedly increased cardiovascular (CV) morbidity and mortality. Chronic inflammation, a hallmark of both CKD and CV diseases (CVD), is believed to drive this association. Pro-inflammatory endogenous TLR agonists, Damage-Associated Molecular Patterns (DAMPs), have been found elevated in CKD patients' plasma and suggested to promote CVD, however, confirmation of their involvement, the underlying mechanism(s), the extent to which individual ...